Epidemiological Profile of HIV/AIDS in Minnesota

Co-infections: HIV and other infectious disease co-infections

Download this document: (PDF: 36KB/2 pages) or (MS Word: 22KB/2 pages)

Risk factors for HIV infection are common to other diseases, namely other STDs (such as chlamydia, gonorrhea and syphilis), hepatitis B and hepatitis C. Also, having an STD may make an individual more susceptible to HIV infection and vice versa. Although Minnesota is considered a low to medium incidence state for chlamydia, gonorrhea and syphilis, many people infected with these STDs are also at risk for acquiring HIV.

HIV and STD co-infection

In the state of Minnesota, laboratory-confirmed infections of chlamydia, gonorrhea, syphilis, and chancroid are monitored by MDH through a passive, combined physician and laboratory-based surveillance system. State law (Minnesota Rule 4605.7040) requires both physicians and laboratories to report all cases of these four bacterial STDs directly to MDH. In 2002, MDH added an active component to the surveillance system for chlamydia and gonorrhea infections, and in 2008 changed the case report form to include gender of sexual partners and country of origin to better describe STDs in Minnesota. In addition to the regular surveillance, additional behavioral information is collected on syphilis and gonorrhea cases. Other common sexually transmitted conditions caused by viral pathogens, such as herpes simplex virus (HSV) and human papillomavirus (HPV) are not reported to MDH. Factors that impact the completeness and accuracy of the available data on STDs include: level of screening, accuracy of diagnostic tests, and compliance with case reporting. Thus, any changes in STD rates may be due to one of these factors, or due to actual changes in STD occurrence.

In 2012, 18,048 chlamydia cases and 3,082 gonorrhea cases were reported to MDH. Nearly 70 percent of chlamydia and gonorrhea cases reported to the MDH were among females and 67 percent were among persons aged 15-24. Minnesota has also seen resurgence in syphilis cases reported to the MDH. In 2012, the number of early syphilis cases (that is, primary, secondary, and early latent stages) decreased by 18 percent (from 260 cases in 2011 to 214 cases in 2012). Of the 214 cases, 47 percent reported being co-infected with HIV. Most of these cases had been diagnosed with HIV before being diagnosed with syphilis.

HIV and viral hepatitis co-infection

People with viral hepatitis also share risk factors for HIV including sexual transmission (in the case of hepatitis B) and sharing needles (in the case of hepatitis C). In 2012, there were an estimated 21,064 people living in Minnesota with hepatitis B, and 39,303 living with past or present hepatitis C. Surveillance data from 2012 indicates that around 12 percent of people living with HIV/AIDS are also living with hepatitis B or hepatitis C (4 percent with hepatitis B and 8 percent with hepatitis C). Nationally, it is estimated that one quarter of people living with HIV are also infected with hepatitis C. Hepatitis B or C co-infection may lead to treatment complications with HIV/AIDS and vice versa.

HIV and TB co-infection

Tuberculosis (TB) co-infection may also be a problem among persons with HIV/AIDS. TB infection after HIV diagnosis is considered to be an AIDS-defining condition. In 2012, 162 new cases of TB were reported in Minnesota, and there were 261 documented cases of people living with TB or receiving treatment for TB. At least 156 (2%) of persons living with HIV/AIDS in Minnesota indicated TB co-infection at some point (46 percent with disseminated TB and 54 percent with pulmonary TB).

 

Updated Monday, May 05, 2014 at 08:50AM